US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist
  • 1.740
  • +0.050+2.96%
Close Feb 14 16:00 ET
  • 1.730
  • -0.010-0.57%
Post 20:01 ET
281.12MMarket Cap1.57P/E (TTM)

Neumora Therapeutics Key Stats

Neumora Therapeutics Q4 2024 Estimates Date

Currency:USDMar 3, 2025

Estimate YoY
Revenue
0
--
EPS
-0.42
+40.53%
Strong Buy

Feb 5, 2025

Neumora Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
Mar 3, 20252024/Q4-- / 0.000--
Nov 12, 20242024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
Mar 3, 20252024/Q4-- / 0.000--
Nov 12, 20242024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Neumora Therapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 5, 2025

Strong Buy

  • Buy

    85.71%
  • Hold

    14.29%
  • Sell

    0.00%

Price Target

No Data